Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    P48 - Novel Therapeutics and Targeted Therapies - EGFR

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 17
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P48.04 - EGFR Germline Mutations in Chinese Lung Cancer Patients: A Single Institutional, Retrospective Study

      00:00 - 00:00  |  Presenter: Chengzhi Zhou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P53 - Novel Therapeutics and Targeted Therapies - Others

    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 8
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P53.07 - Clinical and Genomic Insights Into of Chinese Lung Cancer Patients with HER2 Amplification

      00:00 - 00:00  |  Presenter: Chengzhi Zhou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P60 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Other Biomarkers

    • Type: Posters
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • Presentations: 14
    • Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
    • +

      P60.07 - Comprehensive Genomic Profiling of Microsatellite Instability-High Lung Cancer in China

      00:00 - 00:00  |  Presenter: Chengzhi Zhou

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA02 - RET and Novel Combinations of Osimertinib

    • Type: Mini Oral
    • Track: Novel Therapeutics and Targeted Therapies
    • Presentations: 8
    • Coordinates: 9/08/2021, 09:30 - 10:30, Program Auditorium
    • +

      MA02.01 - Efficacy and Safety of Selpercatinib in Chinese Patients With RET Fusion-Positive Non-Small Cell Lung Cancer: A Phase 2 Trial

      09:30 - 09:35  |  Presenter: Shun Lu

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.